Tenderwize
Back to tender search

Glatiramer acetate medicines

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Nov 29, 2027 · 374 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Glatirameracetat (ATC: L03AX13)

58/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

58 / 100

Complexity

62 / 100

Risk factors

No contract value, expected demand, quantities or minimum purchase commitment is stated.

Contracts may be ended if the buyer later tenders exclusive agreements for the relevant active substances.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Sachsen - Anhalt
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Nov 29, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Conclusion of non-exclusive rebate agreements under §130a(8) SGB V.
  • Supply of finished medicinal products containing glatiramer acetate, ATC L03AX13.
Show full summary

Open-house model for non-exclusive rebate agreements under §130a(8) SGB V covering finished medicinal products containing glatiramer acetate (ATC L03AX13). Every pharmaceutical company or consortium meeting the participation conditions may conclude a contract on identical terms; there is no exclusivity or individual negotiation. The contract may start from 1 February 2026 and ends on 31 January 2028 at the latest. No estimated value is provided. The procurement documents were not analyzed; only structured notice data and an extracted TED XML notice are available.

Risks

No contract value, expected demand, quantities or minimum purchase commitment is stated.

Contracts may be ended if the buyer later tenders exclusive agreements for the relevant active substances.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The participant must be a pharmaceutical company or a community of pharmaceutical companies.
  • The contract is non-exclusive and may be concluded at any time during the participation period on the same conditions.

Administrative

  • Participation documents requested from the buyer must be completed fully and signed.

Requirements may be incomplete.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Glatiramer acetate medicinal products

Non-exclusive rebate agreement for finished medicinal products containing glatiramer acetate (ATC L03AX13) under an open-house model. Eligible pharmaceutical companies may join at any time on identical terms. No exclusivity or individual contract negotiations are provided. The lot information is based on structured tender data and the extracted XML notice.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Deadline

Deadline Nov 29, 2027

Procurement Details

Publication date
07 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
812262-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy